Prosecution Insights
Last updated: October 04, 2026

Texas Tech University System

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

24 pending office actions • 13 art units • 24 examiners • 0 of 24 (0%) have an AI response strategy ready • 28 patents granted in the last 365 days

Analysis

Texas Tech University System is currently managing 21 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 11 distinct art units, suggesting that the university's research and development efforts cover a wide array of specialized biological and pharmaceutical sub-fields. This high number of art units relative to the 21 pending office actions indicates that the portfolio is subject to many different examination standards.

The prosecution involves distinct examiners for every pending office action, meaning that each case is currently being handled by a different individual. YVONNE RENEE ABBOTT-LEWIS is identified as the busiest examiner, though she is responsible for only 1 pending office action. This lack of examiner overlap means that the university cannot rely on consistent patterns with any single examiner to streamline its 21 pending matters.

For practitioners, this portfolio structure requires a highly individualized approach to each application. Because the pending office actions are spread across the 11 distinct art units and various examiners, there is no central bottleneck or primary point of contact. Success in the Biotechnology & Pharmaceuticals sector for this entity depends on the ability to navigate different sets of examiner expectations and the various art unit cultures simultaneously, including the 1 pending office action under the busiest examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

24
Total Pending OAs
14
Non-Final OAs
9
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
3
Due this month
0
Due in next 60 days
4
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (3)Due later (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

9
Hard (38%)
12
Medium (50%)
3
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only5 (21%)
§102 only3 (12%)
§112 only3 (12%)
Double-patenting + other4 (17%)
Multi-statute (no §101)9 (38%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
12% of docket
9
Business / Other
38% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

240 h
Manual time on pending OAs
48 h
Time saved (low, 20%)
84 h
Time saved (mid, 35%)
2.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MAI, HAO D 1 49.3% +39.3%
ABBOTT-LEWIS, YVONNE RENEE 1 78.2% +8.0%
YIP, JACK 1 33.0% +37.8%
IBRAHIM, MEDINA AHMED 1 87.4% +12.2%
COLEMAN, BRENDA LIBBY 1 74.9% +15.5%
YOUNG, WILLIAM D 1 54.3% +15.2%
FADUL, PHILIPMARCUS T 1 81.6% +11.7%
DRODGE, JOSEPH W 1 78.2% +38.2%
GOOD, KENNETH W 1 73.5% +19.0%
GABEL, GAILENE 1 75.6% +44.8%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18854789 RECONSTRUCTION OF THE COTTON FIBER LENGTH DISTRIBUTION FROM A FIBROGRAM FADUL, PHILIPMARCUS T —

Hard Cases (9)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18011453 PROCESSES FOR ELECTROCHEMICAL UP-CYCLING OF PLASTICS AND SYSTEMS THEREOF WONG, EDNA 36d overdue
17782768 METHOD AND COMPOSITIONS FOR ENGINEERING GRAPEVINE RED BLOTCH VIRUS-RESISTANT GRAPEVINE RADOSAVLJEVIC, ALEKSANDAR 13d
18290113 TISSUE-CULTURE INDEPENDENT GENE EDITING OF CELLS BY A LONG-DISTANCE RNA TRANSPORT SYSTEM DELEO, VICTORIA LYNN 77d
19210906 SYSTEMS AND DEVICES FOR THE DELIVERY OF TAILORABLE MEDICAMENT TO THE GINGIVAL CREVICE AND METHODS THEREOF MAI, HAO D —
19172058 AUTOMATED CANINE LINE-UP FOR DETECTION DOG RESEARCH ABBOTT-LEWIS, YVONNE RENEE —
18993995 MODIFIED PLANTS AND SEEDS WITH ENHANCED PHYSIOLOGICAL PERFORMANCE AND ENVIRONMENTAL STRESS RESISTANCE IBRAHIM, MEDINA AHMED —
18838750 MACROPOROUS GRAPHENE MEMBRANE DRODGE, JOSEPH W —
18744403 MICRODEVICE FOR CELL SEPARATION UTILIZING ACTIVATION PHENOTYPE GABEL, GAILENE —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19210906 SYSTEMS AND DEVICES FOR THE DELIVERY OF TAILORABLE MEDICAMENT TO THE GINGIVAL CREVICE AND METHODS THEREOF MAI, HAO D —
19086007 EQUINE NASOGASTRIC TUBE MODEL AND RELATED METHODS YIP, JACK —
18993995 MODIFIED PLANTS AND SEEDS WITH ENHANCED PHYSIOLOGICAL PERFORMANCE AND ENVIRONMENTAL STRESS RESISTANCE IBRAHIM, MEDINA AHMED —
18975409 Modified Tetracycline for Treatment of Alcohol Use Disorder, Pain and Other Disorders Involving Potential Inflammatory Processes COLEMAN, BRENDA LIBBY —
18930686 HOLLOW MICROSPHERES FOR BIOLOGICAL ISOLATION AND RECOVERY YOUNG, WILLIAM D —
18854789 RECONSTRUCTION OF THE COTTON FIBER LENGTH DISTRIBUTION FROM A FIBROGRAM FADUL, PHILIPMARCUS T —
18838750 MACROPOROUS GRAPHENE MEMBRANE DRODGE, JOSEPH W —
18728142 Microwave Architecture for Passive Sensing Applications GOOD, KENNETH W —

Top Art Units

Art UnitApps
1613 2
1662 2
3772 1
3644 1
3648 1
1622 1
1795 1
1629 1
1628 1
1616 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19210906 SYSTEMS AND DEVICES FOR THE DELIVERY OF TAILORABLE MEDICAMENT TO THE GINGIVAL CREVICE AND METHODS THEREOF MAI, HAO D 3772 §103§112 Non-Final OA — Pending May 16, 2025
19172058 AUTOMATED CANINE LINE-UP FOR DETECTION DOG RESEARCH ABBOTT-LEWIS, YVONNE RENEE 3644 §102§103 Non-Final OA — Pending Apr 07, 2025
19086007 EQUINE NASOGASTRIC TUBE MODEL AND RELATED METHODS YIP, JACK — §103 Non-Final OA — Pending Mar 20, 2025
18993995 MODIFIED PLANTS AND SEEDS WITH ENHANCED PHYSIOLOGICAL PERFORMANCE AND ENVIRONMENTAL STRESS RESISTANCE IBRAHIM, MEDINA AHMED — §102§103§112 Non-Final OA — Pending Jan 13, 2025
18975409 Modified Tetracycline for Treatment of Alcohol Use Disorder, Pain and Other Disorders Involving Potential Inflammatory Processes COLEMAN, BRENDA LIBBY — §102§103§112DP Non-Final OA — Pending Dec 10, 2024
18930686 HOLLOW MICROSPHERES FOR BIOLOGICAL ISOLATION AND RECOVERY YOUNG, WILLIAM D — §102 Non-Final OA — Pending Oct 29, 2024
18854789 RECONSTRUCTION OF THE COTTON FIBER LENGTH DISTRIBUTION FROM A FIBROGRAM FADUL, PHILIPMARCUS T — §103 Non-Final OA — Pending Oct 07, 2024
18838750 MACROPOROUS GRAPHENE MEMBRANE DRODGE, JOSEPH W — §102§103§112 Non-Final OA — Pending Aug 15, 2024
18728142 Microwave Architecture for Passive Sensing Applications GOOD, KENNETH W 3648 §103 Final Rejection — Pending Jul 11, 2024
18744403 MICRODEVICE FOR CELL SEPARATION UTILIZING ACTIVATION PHENOTYPE GABEL, GAILENE — §102§103§112Other Non-Final OA — Pending Jun 14, 2024
18626439 Preparation of Chitin Nanocrystals and Nanowhiskers from Crustacean Biomass Using Ionic Liquid GALSTER, SAMUEL LEONARD — §102§103§112 Non-Final OA — Pending Apr 04, 2024
18697938 Selenium Containing Antimicrobial Compound as a Reacitve Dye and Cross-Linking Treatment for Textile Applications STEVENS, MARK V 1613 §102§103§112DP Non-Final OA — Pending Apr 02, 2024
18694966 GFRA2 ANTIBODIES AND THEIR USE IN CANCER TREATMENT NATARAJAN, MEERA — §112 Non-Final OA — Pending Mar 23, 2024
18290113 TISSUE-CULTURE INDEPENDENT GENE EDITING OF CELLS BY A LONG-DISTANCE RNA TRANSPORT SYSTEM DELEO, VICTORIA LYNN 1662 §103§112 Final Rejection 77d Pending Nov 09, 2023
18256449 BCAA-Lowering Compounds for Prevention and/or Treatment of Alzheimer's Disease and Related Disorders LADD, CAROLYN LOUISE 1622 §112 Non-Final OA 13d Pending Jun 08, 2023
18011453 PROCESSES FOR ELECTROCHEMICAL UP-CYCLING OF PLASTICS AND SYSTEMS THEREOF WONG, EDNA 1795 §103§112 Final Rejection 36d overdue Pending Dec 19, 2022
17956249 DISULFIRAM AND OTHER REDOX-RELATED COMPOSITIONS FOR BRAIN TUMORS BORI, IBRAHIM D 1629 §112 Final Rejection 86d Pending Sep 29, 2022
17909480 TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION FUBARA, BLESSING M 1613 §103§112DPOther Non-Final OA 68d Pending Sep 06, 2022
17908999 MODIFIED TETRACYCLINES FOR TREATMENT OF ALCOHOL USE DISORDER, PAIN AND OTHER DISORDERS INVOLVING POTENTIAL INFLAMMATORY PROCESSES HOWELL, THEODORE R 1628 §102DPOther Final Rejection 71d Pending Sep 02, 2022
17908497 COMPOSITIONS AND METHODS FOR REPELLING ANIMALS FROM AN OBJECT LIU, SUE XU 1616 §103 Final Rejection 99d overdue Pending Aug 31, 2022
17782768 METHOD AND COMPOSITIONS FOR ENGINEERING GRAPEVINE RED BLOTCH VIRUS-RESISTANT GRAPEVINE RADOSAVLJEVIC, ALEKSANDAR 1662 §103§112 Non-Final OA 13d Pending Jun 06, 2022
17630975 Microfluidic Pipette Aspirators for Large-Scale Analysis of Single Cells, Clusters and Their Sub-Populations KRCHA, MATTHEW D 1798 §102 Final Rejection 126d overdue Pending Jan 28, 2022
17521773 SYSTEM AND METHOD FOR ASSESSING EMBRYO VIABILITY HUANG, MICKEY NMN 1758 §102 Final Rejection 29d Pending Nov 08, 2021
17284525 Method to Express, Purify, and Biotinylate Eukaryotic Cell-Derived Major Histocompatibility Complexes YAO, LEI 1642 §103 Final Rejection 35d overdue Pending Apr 12, 2021

Managing Texas Tech University System's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month